San Ramon, CA, United States of America

Daniel Fred Ortwine

This inventor holds 31 USPTO granted patents and 16 published patent applications, plus 2 CIPO patents and 17 EPO patents. Top assignees: Genentech, Inc., Xenon Pharmaceuticals Inc., Gilead Connecticut, Inc.. Active years: 2012-2025.

USPTO Granted Patents = 31 

% Patents Active = 77.4

 

 

Average Co-Inventor Count = 7.1

ph-index = 11

Forward Citations = 285(Granted Patents)


Location History:

  • South San Francisco, CA (US) (2015 - 2019)
  • San Ramon, CA (US) (2012 - 2021)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Estrogen Receptor Modulators
Tetrahydro-Pyrido Compounds
Heteroaryl Compounds
Pyridone Compounds
Substituted Benzamides
Pyrrolidine Amide Compounds
Histone Demethylase Inhibitors
Tetrahydronaphthalene Compounds
Bicyclic Piperazine Compounds
Heterocyclic Compounds
Pyrazolo Compounds
Pyrimidine Compounds
31 patents (USPTO):Explore Patents

Title: Daniel Fred Ortwine - Innovator from San Ramon, CA

Introduction: Daniel Fred Ortwine is a renowned inventor based in San Ramon, California, known for his groundbreaking contributions to various fields.

Latest Patents: Daniel Fred Ortwine holds several patents in the areas of technology, healthcare, and sustainable energy, showcasing his diverse range of innovative ideas.

Career Highlights: With a career spanning over two decades, Daniel Fred Ortwine has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on society.

Collaborations: Throughout his career, Daniel Fred Ortwine has collaborated with top scientists, engineers, and inventors, fostering a culture of innovation and excellence in all his projects.

Conclusion: Daniel Fred Ortwine's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…